Company intelligence / Profile preview

SigTuple

Bangalore, Karnataka, Indiasigtuple.com ↗

Ownership: Private
Development stage: Commercial

Overview

The AI100 with Shonit received U.S. FDA clearance in October 2023 for automated digital microscopy and classification of over thirty cell types from peripheral blood smears. Clinical validation demonstrated improved efficiency and accuracy compared to manual microscopy, enabling remote review by pathologists and supporting diagnosis across a range of hematological conditions.

Therapeutic areas: Infectious DiseasesMen's HealthOphthalmologyHematology
Modalities: DeviceSoftware (AI-powered diagnostics)Robotics platform (for sample handling and imaging)Cloud computing (for tele-diagnostics)
Industry: Pathology

Partnerships

Partnered with research hospitals and medical colleges for data collection/training models.

Beyond the preview

Go deeper on SigTuple.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SigTuple.

Explore the full profile